Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started
My Medicine

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Men's Health

Font Size

Arthritis Drug Slows ALS in Mice

Cox-2 Inhibitors May Help Those With Lou Gehrig's Disease

WebMD Health News


Sept. 25, 2002 -- The latest generation of arthritis drugs may slow the progression of amyotrophic lateral sclerosis (ALS), more commonly known as Lou Gehrig's disease. Research shows the Cox-2 inhibitor Celebrex -- already proved safe and effective for relieving arthritis pain and inflammation -- can also delay symptoms and prolong survival in mice with ALS. And tests in humans are under way.

ALS is a little-understood, always fatal disorder in which the nerve cells that control muscle function slowly deteriorate. Over time, patients develop weakness, muscle spasms, and tremors, eventually becoming paralyzed. Most die within 10 years of diagnosis, about half within three years. And right now, there is no cure.

Hoping to speed research along, Jeffrey D. Rothstein, MD, PhD, and colleagues at Baltimore's Johns Hopkins School of Medicine decided to look only at drugs already FDA approved for human use. That way, he says in a news release, "if we found something to be effective in the animal model, we could then move rapidly into clinical trials -- and that's exactly what happened."

Among the drugs they tested was Celebrex. When they gave it to mice genetically engineered to develop ALS, the animals showed dramatically delayed onset of muscle weakness and weight loss. Plus, they had significantly less spinal nerve cell deterioration and lived 25% longer than did untreated mice.

Because Celebrex is already approved for use in the U.S., says Rothstein, human trials began right away. Initial results of the first study -- investigating whether Celebrex slows progression of the human form of the disease -- should be available in about a year.

There is only one drug -- Rilutek -- approved for treating ALS, and it provides only modest benefits. Patients are advised to get regular exercise to maintain their muscle strength and stave off debilitating cramps and spasms.

Today on WebMD

man coughing
Men shouldn’t ignore.
man swinging in hammock
And how to get out it.
shaving tools
On your shaving skills.
muscular man flexing
Four facts that matter.
Food Men 10 Foods Boost Male Health
Thoughtful man sitting on bed
Man taking blood pressure
doctor holding syringe
Condom Quiz
man running
older couple in bed